Study title: A Single Dose, Randomized, Double-Blind, Double-Dummy, 4-way Crossover Trial Comparing 12 mcg and 24 mcg of Foradil Aerolizer, 180 mcg Albuterol Metered-Dose Inhaler (MDI) Versus Placebo in the Prevention of Exercise-Induced Bronchospasm in Pediatric Pati
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases | |||||
Brands: | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: FORMOTEROL | |||||
ATC code: R03A C13 | |||||
Document link: FOR258D 0402 Art45 listing 2011.xls | |||||
Document date: 2011-11-22 | |||||
Study number: CFOR2580402 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |